PD-L2 is expressed on activated human T cells and regulates their function.

Mol Immunol

Institut National de la Santé et de la Recherche Médicale, Unité 891, Centre de Recherche en Cancérologie de Marseille, F-13009, Marseille, France.

Published: September 2011

T-cell activation and proliferation are regulated by cosignaling adhesion molecules involved in positive or negative signals. Programmed death (PD)-1 is one of immune inhibitory molecules that is expressed in activated T cells and is a promising target for immunotherapy. Both PD-1 ligands, PD-L1 and PD-L2 are expressed on antigen presenting cells (APCs) involved in the dialogue between a T cell and an APC. Here, we analysed the expression of these ligands, especially for PD-L2, on T cells. PD-L2 appears to be expressed on activated CD4 and CD8T cell subsets. Moreover, as PD-1 molecule, PD-L2 engagement at the surface of T cells is able to down-modulate cytokine production and cell proliferation. These observations indicate that PD-L2 is expressed following activation and is involved in the regulation of T cell function, highlighting the level of complexity in the T cell cosignaling network.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2011.06.436DOI Listing

Publication Analysis

Top Keywords

pd-l2 expressed
12
expressed activated
12
pd-l2
6
cells
5
cell
5
activated human
4
human cells
4
cells regulates
4
regulates function
4
function t-cell
4

Similar Publications

PD-L2 act as an independent immune checkpoint in colorectal cancer beyond PD-L1.

Front Immunol

December 2024

Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

Introduction: Immunotherapy, especially immune checkpoint blockade (ICB), holds promise as a therapeutic strategy in colorectal cancer (CRC) by harnessing the patient's immune system to target malignant cells. Particularly, the PD-1/PD-L1 axis is widely recognized for its critical role in tumor microenvironment immunosuppression. Antibodies targeting PD-1 or PD-L1 have shown sustained efficacy against various cancers, including CRC.

View Article and Find Full Text PDF

Effect of decitabine on PD-L2 methylation in whole blood of iodine-induced autoimmune thyroiditis rats.

Ecotoxicol Environ Saf

December 2024

Department of Preventive Medicine, Qiqihar Medical University, Qiqihar, Heilongjiang, China. Electronic address:

Article Synopsis
  • Excessive iodine intake can lead to autoimmune thyroiditis (AIT), with methylation changes in the PD-L2 gene potentially playing a crucial role in this condition.
  • Researchers used Decitabine, a DNA methyltransferase inhibitor, in an experimental model to explore the effects on AIT, involving various biochemical and molecular techniques to assess thyroid function and immune responses.
  • Results indicated that iodine-induced AIT was associated with decreased PD-L2 methylation and increased inflammatory markers, while treatment with Decitabine improved thyroid function trends and altered PD-L2 expression, though more safety evaluations are needed for this potential treatment.
View Article and Find Full Text PDF

Background: Lung adenocarcinoma (LUAD) is the most prevalent subtype of non-small cell lung cancer (NSCLC), characterized by poor prognosis and a high mortality rate. Identifying reliable prognostic biomarkers and potential therapeutic targets is crucial for improving patient outcomes.

Methods: We conducted a comprehensive analysis of HJURP expression in LUAD using data from four cohorts: TCGA-LUAD (n = 453), GSE31210 (n = 226), GSE68465 (n = 442), and GSE72094 (n = 386).

View Article and Find Full Text PDF

Background: Interferon regulatory factor 4 (IRF4) is a crucial member of the IRF family of transcription factors and is pivotal in orchestrating the body's defense against tumors and infections by modulating the differentiation and functionality of immune cells. The role of IRF4 in mice during Schistosoma japonicum infection, as well as the effects of IRF4 deficiency on myeloid-derived suppressor cells (MDSCs), remains inadequately understood.

Methods: Hematoxylin and eosin staining was used to evaluate the pathological damage in different organs of mice following infection with S.

View Article and Find Full Text PDF
Article Synopsis
  • Gastric carcinomas (GCs) are aggressive cancers, with only 15% of patients responding to anti-PD-(L)1 treatments, but those associated with Epstein-Barr virus (EBV) exhibit better responses and unique immune characteristics.
  • A study analyzed tumor immune microenvironments in 25 treatment-naïve GCs, comparing 11 EBV+ and 14 EBV- cases using immunohistochemistry and gene expression profiling.
  • Results showed EBV+ GCs had higher densities of CD8+ T cells and distinct immune gene expression patterns, while EBV- GCs demonstrated increased inflammatory and immunosuppressive gene signatures, suggesting differing mechanisms of immune evasion.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!